Alignment Healthcare, Inc. (NASDAQ: ALHC) is a prominent player in the healthcare sector, focusing on Medicare Advantage plans. The company is known for its commitment to high-quality, member-focused care. It competes with other healthcare providers in the Medicare Advantage space, striving to offer superior services to its members.
On October 9, 2025, Kim Hyong, the Chief Medical Officer of ALHC, sold 51,379 shares of the company's Common Stock at approximately $17.57 each. Despite this sale, Hyong still holds 362,333 shares, indicating a significant personal investment in the company. This transaction comes at a time when ALHC's stock is priced at $17.55, showing a slight decrease of 0.79%.
ALHC's commitment to quality is evident as all its Medicare Advantage members are enrolled in plans rated 4 stars or higher by the Centers for Medicare and Medicaid Services (CMS) for the second year in a row. This achievement underscores the company's dedication to providing exceptional care, as highlighted by its recent addition of a second 5-star HMO contract in Nevada.
The company's Texas HMO has also performed well, earning 4.5 stars in its first year. John Kao, founder and CEO, attributes these high ratings to ALHC's focus on addressing the needs of the aging population. This focus has helped solidify its reputation as a leading performer in the Medicare Advantage sector.
ALHC's stock has experienced fluctuations, with a daily range between $17.34 and $17.82. Over the past year, the stock has seen a high of $21.06 and a low of $10.11. The company has a market capitalization of approximately $3.48 billion, with a trading volume of 2,028,525 shares on the NASDAQ exchange.
